The PI3K/AKT/mTOR pathway seems to play a key role in sarcomas pathogenesis, in line with evidences of dual PI3K/ mTOR inhibition efficacy in uterine leiomyosarcoma patient-derived xenografts [80]. Here, PIK3CA is linked to leiomyosarcoma.